12.22
-0.23 (-1.85%)
| Previous Close | 12.45 |
| Volume | 94,593 |
| Price / Sales | 2.77 |
| Price / Book | 2.34 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -5.03 |
| Total Debt/Equity (MRQ) | 0.98% |
| Current Ratio (MRQ) | 14.80 |
| Operating Cash Flow (TTM) | -18.67 M |
| Levered Free Cash Flow (TTM) | -10.72 M |
| Return on Assets (TTM) | -31.34% |
| Return on Equity (TTM) | -48.57% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Benitec Biopharma Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 3.12% |
| % Held by Institutions | 85.44% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Simplify Asset Management Inc. | 30 Jun 2026 | 1,005,557 |
| Silverarc Capital Management, Llc | 30 Jun 2026 | 679,826 |
No data within this time range.
No data within this time range.
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 01 Jun 2018 | - | 08 Jun 2018 | 0.002929 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2018 | 0.003 | 1 | 0.00 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |